IL-17A, which is the most abundant cytokine in ankylosing spondylitis sera and synovial fluid, enhanced osteoblast activity by increasing phosphorylated JAK2 (p-JAK2), total JAK2, and phospho-STAT3 (Tyr705) signalling. Here, JAK2 is linked to ankylosing spondylitis.